ArticleFrontiers in medicine2026

Comparative safety of denosumab and romosozumab in osteoporosis: an analysis based on the FDA adverse event reporting system database.

Jian Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.